Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience on behalf of the French CANCERVIH network

Jean Philippe Spano,Marianne Veyri,Aurélien Gobert,Amélie Guihot,P. Perré,Mallorie Kerjouan,Solenn Brosseau,N. Cloarec,Henri Montaudie,Carole Helissey,Thomas Flament,Valérie Gounant,Armelle Lavole,Isabelle Poizot-Martin,Christine Katlama

Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience on behalf of the French CANCERVIH network

2019

Jean Philippe Spano
Marianne Veyri
Aurélien Gobert
Amélie Guihot
P. Perré
Mallorie Kerjouan
Solenn Brosseau
N. Cloarec
Henri Montaudie
Carole Helissey
Thomas Flament
Valérie Gounant
Armelle Lavole
Isabelle Poizot-Martin
Christine Katlama

AbstractObjective:To report efficacy and tolerance of nivolumab or pembrolizumab, PD-1 inhibitors, in people living with HIV (PLWHIV) and cancer.Design:Series of PLWHIV cancer patients treated with anti-PD1 agents in real life clinical practice.Methods:From May 2014 to January 2019, 575 HIV infected

Keywords:

Nivolumab
Immunology
Immunotherapy
Oncology
Cancer
Pembrolizumab
Internal medicine
Medicine
in real life
human immunodeficiency virus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations